Novel Antimicrobials and AMR Diagnostics 2019

News

Clearer picture on antibiotic resistance

The Centers for Disease Control and Prevention (CDC) are working towards an update of their Antimicrobial Resistance Threats Report in fall 2019.



New multidrug-resistant tuberculosis drug under observation

A phase 3 trial of delamanid, a newer oral drug for treating multidrug-resistant tuberculosis (MDR-TB), found no statistically significant reduction...



Panel discussion on AMR

During the Grand Challenges meeting of Bill and Melinda Gates Foundation in October 2018, there was a panel discussion devoted to antimicrobial...



New drug resistant bacteria found

In China, two new bacteria species have been found in patients’s blood. They were found during a routine blood test, the Microbiology Society reports....



Forbes: Why animal health startups should be thinking about antibiotics

An article in Forbes explores, why more startups in animal health should develop novel antibiotics and why biotechnology innovation is needed.



CDC: New antibiotic resistance threats report expected for 2019

Stat news reports an expert opinion according to which CDC will release an updated “Antibiotic Resistance Threats in the United States” report in the...



Two new species of antibiotic resistant bacteria found in China

Researchers of Sichuan University, China, report that they have discovered two new species of resistant bacteria in the blood of patients.



Ares Genetics advances AI-powered antibiotic resistance test

Curetis’ subsidiary Ares Genetics advances AI-powered antibiotic resistance test within a new project co-funded by Vienna Business Agency.

 



CDC awards US$15m to find solutions for AMR

The US Centers for Disease Control & Prevention (CDC) has awarded more than US$15m for innovative research to combat antibiotic resistance.



France and Germany launch joint call for AMR projects

The French and German research ministries are launching their first joint call for projects on antimicrobial resistance.



Forge Therapeutics receives 2nd CARB-X award

Forge Therapeutics, Inc., a biotechnology company developing novel medicines targeting metalloenzymes, announced that it has received a second CARB-X...



Novartis provides data to SPARK

Novartis is donating data from its abandoned antibiotic research programmes on Pew's open-access SPARK.



AMR Diagnostic Challenge names five finalists

The AMR Diagnostic Challenge seeks innovative, rapid point-of-care laboratory diagnostic tests to combat the development and spread of drug resistant...



Thinking about how to fund AMR activities

How can AMR innovation be financed? A development dialogue paper by the Dag Hammarskjöld Foundation and the ReAct Initiative attempts to answer this...



NICE published impact report on AMR

In November, the British National Institute for Health and Care Excellence (NICE) published an impact report on antimicrobial resistance. The report...



Are novel antibiotics worth investing in?

Overview about current discussion about Push and Pull incentives/ New initiative started by SMEs to propel preclinical research



GARDP, Eisai, and Takeda join forces in the search for novel antibiotics

Novel chemical compounds ready to be screened for antibacterial activity



JPI AMR Joint Transnational Call 2019 launched

Funding available for transnational research projects developing diagnostic and surveillance tools to combat AMR



AMR Special Issue of Microbiologist published

Ten commandments on antimicrobial resistance



New European CARB-X Accelerator in Switzerland

BaselArea.swiss successfully applied to join CARB-X Global Accelerator Network



BEAM member Phagomed – Ted Talk & Founder award

Biotech entrepreneur with TED Talk about phages and Phagomed



British F2G Biotech bags €24m

The European Investment Bank (EIB) has lent antiinfectives company F2G Biotech Ltd €24m for antifungal research and innovation under the InnovFin...



Novo Nordisk Foundation to focus on emerging infectious diseases

Through its Challenge Programme, the Novo Nordisk Foundation is focusing on research on emerging infectious diseases. Applications may be submitted...



Antibiotic resistance spreading across Europe

Antimicrobial resistance (AMR) has increased by 32% since 2007 in Europe, according to a brand new report.